Membio is on a mission to eliminate the worldwide shortage of blood by manufacturing it outside the body. Using “bleeding edge” technologies we can make an unlimited supply of fully functional and universally accepted red blood cells. All pun’s aside, we are able to make this work by removing the need for a donor by using an “immortalized” cell line which can replicate indefinitely before transforming in a red blood cell. By combining these immortalized cells with Membio’s cell therapy manufacturing technology enables us to unlock cost-effectively production of red blood cells on an industrial scale.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):